Quanta Inc (fka QNTA)

[~MulaGreen~]

News:Medolife Rx Clinical Observations Demonstrates Effectiveness Of Escozine In Complementary Use With COVID-19 Vaccines

https://finance.yahoo.com/news/medolife-rx-announces-successful-stability-123000414.html

BURBANK, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that the Company has completed a stability study on its lead drug candidate Escozine® that was conjugated with radioactive iodine, showing strong stability throughout the study. The preclinical study took place in preparation for next steps of the Company’s clinical trials on Escozine® under the guidelines of the US Food and Drug Administration (FDA).

“Beyond our successful stability result on Escozine’s peptide conjugated with radioactive iodine, we were even more excited by its potential applications in the field of diagnostics,” said Medolife CEO Dr. Arthur Mikaelian. “We hope that those who follow our company see how quickly we are moving in this process since receiving our response from the FDA. These programs generally take years and we have wasted no time since receiving the guidelines in preparing for our next steps. We are extremely confident in Escozine’s potential palliative and therapeutic benefits and look forward to updating those interested as soon as possible.”